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Figure S1.  
(A) Anti-TNF-α treatment normalizes TRUC colon weights. Mice were treated with 
anti-TNF-α or isotype control from 4 wks of age through 8 wks of age on a weekly 
dosing schedule. Representative data from 1 of 3 independent experiments are shown. 
(B) There is increased apoptosis in the colonic epithelium of TRUC mice. TUNEL+ 
cells and the number of epithelial cells per crypt were counted across all 4 genotypes. 
5 slides were generated from each genotype group (2-3 mice per genotype). Areas of 
the large bowel were randomly selected and epithelial cells, epithelial crypts, and 
TUNEL+ epithelial cells were counted. A minimum of 500 crypts per genotype were 
scored. (C) Anti-TNF-α treatment cures TRUC colitis when initiated prior to disease 
onset. Mice were treated with anti-TNF-α or isotype control from 2 wks of age 
through 6 wks of age, representative data from one of 2 independent experiments are 
shown, p =.002. (D) Anti-TNF-α treatment cures TRUC colitis when initiated during 
fulminate disease. Mice were treated with anti-TNF-α or isotype control from 8-12 
wks of age, representative data from one of 2 independent experiments are shown, p = 
.012. Where shown, error bars denote standard deviation (SD). 
